Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Poggi

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
International Journal of Cancer|September 21, 2010
Differential survival of γδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL-expressing leukemic cellsAlessandro Poggi, Marta Zancolli, Silvia Boero, et al.
Frontiers in Immunology|September 26, 2022
Editorial: Emerging roles and mechanisms of stromal cells in carcinomas at the molecular levelJaewoo Hong, Jun-O Jin, Wei-Yu Chen, et al.
European Journal of Immunology|August 23, 2005
Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptorsAlessandro Poggi, Paola Contini, Silvia Catellani, et al.
Cancers|April 13, 2024
EGFR-Targeted Antibody-Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma CellsLeila Pisheh, Serena Matis, Martina Taglieri, et al.
Annals of the New York Academy of Sciences|September 6, 2007
NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cellsAlessandro Poggi, Claudia Prevosto, Marta Zancolli, et al.
Current Medicinal Chemistry|January 29, 2008
Adhesion molecules and kinases involved in gammadelta T cells migratory pathways: implications for viral and autoimmune diseasesAlessandro Poggi, Silvia Catellani, Daniela Fenoglio, et al.
Cells|May 24, 2024
Antibody-Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab-Vedotin Exert Anti-Lymphoma and Immunostimulating EffectsFeliciana Morelli, Serena Matis, Roberto Benelli, et al.
Transfusion|January 11, 2011
Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-β(1), soluble Fas ligand, and soluble Class I human leukocyte antigenMassimo Ghio, Paola Contini, Simone Negrini, et al.
British Journal of Haematology|September 4, 2010
Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cellsAlessandro Poggi, Claudia Prevosto, Silvia Catellani, et al.
Cancer Letters|April 29, 2017
The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancerAntonella Brizzolara, Roberto Benelli, Roberta Venè, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|September 21, 2010
Differential survival of γδT cells, αβT cells and NK cells upon engagement of NKG2D by NKG2DL-expressing leukemic cellsAlessandro Poggi, Marta Zancolli, Silvia Boero, et al.
Frontiers in Immunology|September 26, 2022
Editorial: Emerging roles and mechanisms of stromal cells in carcinomas at the molecular levelJaewoo Hong, Jun-O Jin, Wei-Yu Chen, et al.
European Journal of Immunology|August 23, 2005
Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptorsAlessandro Poggi, Paola Contini, Silvia Catellani, et al.
Cancers|April 13, 2024
EGFR-Targeted Antibody-Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma CellsLeila Pisheh, Serena Matis, Martina Taglieri, et al.
Annals of the New York Academy of Sciences|September 6, 2007
NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cellsAlessandro Poggi, Claudia Prevosto, Marta Zancolli, et al.
Current Medicinal Chemistry|January 29, 2008
Adhesion molecules and kinases involved in gammadelta T cells migratory pathways: implications for viral and autoimmune diseasesAlessandro Poggi, Silvia Catellani, Daniela Fenoglio, et al.
Cells|May 24, 2024
Antibody-Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab-Vedotin Exert Anti-Lymphoma and Immunostimulating EffectsFeliciana Morelli, Serena Matis, Roberto Benelli, et al.
Transfusion|January 11, 2011
Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-β(1), soluble Fas ligand, and soluble Class I human leukocyte antigenMassimo Ghio, Paola Contini, Simone Negrini, et al.
British Journal of Haematology|September 4, 2010
Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cellsAlessandro Poggi, Claudia Prevosto, Silvia Catellani, et al.
Cancer Letters|April 29, 2017
The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancerAntonella Brizzolara, Roberto Benelli, Roberta Venè, et al.
Pageof 17